Blog Posts
Cell and gene therapies: Managing COVID-19 disruptions, both upstream and downstream
The time-sensitive, temperature-sensitive supply chain for cell-and-gene therapies (CGT) requires a highly coordinated, highly choreographed dance under the best of...
Battery Performance Offers Insight into Active Container Quality
As the world awaits a COVID-19 vaccine, the cold chain industry is doing everything possible to prepare for the eventual...
COVID-19 Vaccine Distribution: Packaging an End to the Pandemic
It seems that about once every two or three weeks, my oldest child will ask me, “Dad, when will COVID...
The Meaning of “Temperature assured. Life enhanced.”
CSafe is a purpose driven company whose employees come to work every day knowing that what they do will have...
Achieving Irrefutable Chain of Custody for Cell & Gene Therapies with Smart Technologies
Chain of custody (COC) in the simplest of terms, details the location and time an item changed hands and who...
The Fundamentals of Extracting Data from the Cold Chain
Innovation comes in many forms and when it comes to extracting data from the cold chain for customers. Tom Weir,...
The True Cost of a Cell & Gene Payload
As the cell and gene industry continues to grow manufacturers must determine where it is – and is not –...
Artificial Intelligence Finally Goes Cold
Tom Weir, Chief Operating Officer for CSafe Global discusses why it has taken so long for AI to come to...
Safeguarding the Cell & Gene Supply Chain – Building Flexibility
Emilio Frattaruolo, CPP, Vice President of Innovation, Passive Systems discusses how to build flexibility into the cell and gene therapy...
CSafe Global: Built to Excel in Crisis Situations
CSafe Global has a history and mission that has positioned us to perform over and above industry standards no matter...